SINGAPORE (Nov 22): Raffles Medical Group has seen its share price retrace 14% from its year-to-date high of $1.63. But UOB Kay Hian believes this provides an “attractive entry opportunity” into the health care provider.
“We see the recent share price pullback as a buying opportunity as longer-term fundamentals remain solid and we are positive on RMG’s long-term prospects,” says UOB lead analyst Andrew Chow in a report on Friday.
UOB is keeping Raffles Medical Group at “buy” with a target price of $1.70.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
